Welcome to The Coolest Nicknames

Comments

Googlism comments

Sanofi is now experiencing
Sanofi is now experiencing decreased email traffic and mail volume
Sanofi is currently not holding any discussions about a merger with another pharmaceuticals company and that it also does not need a
Sanofi is a french multi
Sanofi is a french company
Sanofi is the global pharmaceutical company with headquarters in paris
Sanofi is dedicated to bringing innovative medicine to the international community
Sanofi is proposing to extend dehecq's retirement age beyond 65 to allow him to stay at the helm until 2008
Sanofi is targeting 800 million euros in sales for arixtra by 2006
Sanofi is the most local of incipient big pharmas
Sanofi is strong
Sanofi is running two other 990
Sanofi is planning a board meeting wednesday
Sanofi is running two other 990 person studies looking at the effects of the drug in patients with diabetes and lipid problems
Sanofi is amongst the top 20 pharmaceutical companies in the world and fifth largest in europe
Sanofi is currently seeking product licence approval for oxaliplatin in europe via the mutual recognition procedure with france as rapporteur and will submit a
Sanofi is focusing on five lines of research
Sanofi is a paris
Sanofi is expected to continue to see solid growth rates
Sanofi is not being "fast tracked" through
Sanofi is now starting final phase iii trials of the product
Sanofi is likely to benefit from viropharma’s research
Sanofi is joining the protfolio
Sanofi is france's second biggest drug company
Sanofi is developing candidate medicines for unstable angina and atrial fibrillation
Sanofi is europe's fastest
Sanofi is the world leader with its brand
Sanofi is confident that 2003 sales of plavix will total around $2 billion
Sanofi is a us
Sanofi is working on a weight
Sanofi is expected to use its own brand name to promote the drug
Sanofi is keen to do a deal that would boost its us presence but mark clark
Sanofi is also understood to have shown interest in jb’s two new drug delivery systems for ranitidine and metronitodazole
Sanofi is also undertaking the registration of our alpha
Sanofi is known to be considering off
Sanofi is in a joint venture with a large pharmaceutical company in which their combined sales forces are co
Sanofi is
Sanofi is pushing it to phase iii trials in the us
Sanofi is likely to benefit from viropharma's research
Sanofi is uitermate schadelijk voor schering
Sanofi is officially locked up until the end of 2004 by french conglomerates totalfinaelf sa and l'oreal sa
Sanofi is a nonpeptide compound which possesses neurotrophin
Sanofi is aggrieved and seeks to have the trade mark registration removed in respect of pharmaceutical preparations other than
Sanofi is deciding if further studies should be performed
Sanofi is seeking to recover from cygnus approximately $60
Sanofi is the first corporate client to acquire office space in this large new development owned by the french pension fund
Sanofi is one of the 25 largest pharmaceuticals groups and ranks among the 10 leading producers of luxury perfumes and beauty products
Sanofi is the world's fastest
Sanofi is among the top 30 health laboratories in the world
Sanofi is supposed to have the results of the study sometime this summer and i am curious to see what they will be
Sanofi is not going to tell any of the study participants whether or not they got the drug or the placebo until the study is over
Sanofi is one of the fastest growing european pharmaceutical companies
Sanofi is working on
Sanofi is looking to quickly resolve issues the us food and drug administration has raised about its new blood thinner arixtra
Sanofi is apparently misleading
Sanofi is a new drug for the treatment of paget's disease
Sanofi is financing a specialised training of young african doctors in the fight against malaria
Sanofi is the healthcare and beauty products division of société nationale elf aquitaine